Jim Simons Cti Biopharma Corp Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$5.36 - $7.43 $2.24 Million - $3.1 Million
-417,093 Reduced 94.02%
26,520 $154,000
Q2 2022

Aug 12, 2022
SELL
$3.55 - $6.27 $2.37 Million - $4.19 Million
-667,800 Reduced 60.09%
443,613 $2.65 Million
Q1 2022

May 13, 2022
SELL
$1.9 - $5.23 $463,600 - $1.28 Million
-244,000 Reduced 18.0%
1,111,413 $5.19 Million
Q4 2021

Feb 11, 2022
SELL
$1.44 - $2.86 $625,082 - $1.24 Million
-434,085 Reduced 24.26%
1,355,413 $3.36 Million
Q3 2021

Nov 12, 2021
SELL
$2.25 - $3.18 $1.46 Million - $2.06 Million
-648,935 Reduced 26.61%
1,789,498 $5.28 Million
Q2 2021

Aug 13, 2021
BUY
$2.16 - $2.62 $1.79 Million - $2.17 Million
827,620 Added 51.38%
2,438,433 $6.1 Million
Q1 2021

May 13, 2021
SELL
$2.68 - $3.8 $504,799 - $715,760
-188,358 Reduced 10.47%
1,610,813 $4.69 Million
Q4 2020

Feb 10, 2021
SELL
$2.48 - $3.8 $983,161 - $1.51 Million
-396,436 Reduced 18.06%
1,799,171 $5.79 Million
Q3 2020

Nov 13, 2020
BUY
$1.02 - $2.15 $93,651 - $197,402
91,815 Added 4.36%
2,195,607 $4.72 Million
Q2 2020

Aug 13, 2020
BUY
$0.88 - $1.32 $15,547 - $23,321
17,668 Added 0.85%
2,103,792 $2.44 Million
Q1 2020

May 14, 2020
BUY
$0.69 - $1.54 $81,564 - $182,043
118,210 Added 6.01%
2,086,124 $1.92 Million
Q4 2019

Feb 13, 2020
BUY
$0.72 - $1.64 $64,818 - $147,641
90,025 Added 4.79%
1,967,914 $3.11 Million
Q3 2019

Nov 13, 2019
BUY
$0.64 - $0.92 $180,033 - $258,797
281,302 Added 17.62%
1,877,889 $1.57 Million
Q2 2019

Aug 12, 2019
BUY
$0.8 - $1.03 $251,388 - $323,662
314,235 Added 24.5%
1,596,587 $1.37 Million
Q1 2019

May 14, 2019
BUY
$0.9 - $1.37 $175,592 - $267,291
195,103 Added 17.94%
1,282,352 $1.24 Million
Q4 2018

Feb 13, 2019
BUY
$0.73 - $2.19 $793,691 - $2.38 Million
1,087,249 New
1,087,249 $798,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email